Hyperhomocysteinaemia Promotes Doxorubicin-Induced Cardiotoxicity in Mice

Doxorubicin, a widely used chemotherapeutic drug in clinical oncology, causes a series of cardiac side effects referred to as doxorubicin-induced cardiotoxicity. Hyperhomocysteinaemia is an independent risk factor for multiple cardiovascular diseases. However, whether hyperhomocysteinaemia contribut...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Rui, Wang, Yao, Zhang, Jinjin, An, Xiangbo, Liu, Shuang, Bai, Jie, Li, Jiatian, Lin, Qiuyue, Xie, Yunpeng, Liao, Jiawei, Xia, Yunlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534320/
https://www.ncbi.nlm.nih.gov/pubmed/37765020
http://dx.doi.org/10.3390/ph16091212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534320/
https://www.ncbi.nlm.nih.gov/pubmed/37765020
http://dx.doi.org/10.3390/ph16091212

Ejemplares similares